The US FDA has granted QuidelOrtho Corporation 510(k) clearance for the VITROS hs Troponin I Reagent Pack. The assay is intended for the quantitative measurement of cardiac troponin I (cTnI) in human plasma (heparin) to aid in the diagnosis of myocardial infarction (MI). The VITROS Systems are built on dry-slide, MicroWell and INTELLICHECK Technologies designed to deliver workflow efficiency, reliability, and quality clinical results. Further information is available online.